The invention relates to a topical pharmaceutical composition for burn treatment and microbial infections on human beings or animals. The pharmaceutical composition comprises 0.1% w/w to 1.0% w/w of an antimicrobial drug, i.e., silver sulfadiazine and 0.2% w/w antiseptic, i.e., chlorhexidine gluconate, wherein silver sulfadiazine is in nanonized form.

The invention relates to a topical pharmaceutical composition for burn treatment and microbial infections on human beings or animals. The pharmaceutical composition comprises 0.1% w/w to 1.0% w/w of an antimicrobial drug i.e. silver sulfadiazine and 0.2% w/w antiseptic i.e. chlorhexidine gluconate wherein silver sulfadiazine is in nanonized form.

The present invention relates to a means consisting of a micro- and/or nanofibrous fabric with quaternary nitrogen grafted by radiation thereon wherein the amount of the quaternary nitrogen is in the range of about 1 to about 30 percent by weight, based on the total weight of the micro- and/or nanofibrous fabric. The means further comprises colloidal silver and/or silver added sulfadiazine and/or silver bound to a thiol functional group of bifunctional anion exchange resin in an amount of about ...

By combining the anti-bacterial effects of silver sulfadiazine and silver nanoparticles with the absorption and slow-release capabilities of alginate a product was created that can be used to heal and protect deep wounds. These microparticles can have a greater surface area to volume ratio. This in turn can permit the particles to have a larger area of exposure to bacterial colonies thereby increasing antimicrobial activity. Additionally engineered microparticles also may benefit from the abilit...